---

---

tags : Presentation    source : Www.globenewswire.com   

save search

---

Immix Biopharma Announces Late-Breaking NXC-201 Clinical Data Abstract Accepted for Oral Presentation at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-15 (Crawled : 14:00) - globenewswire.com
IMMX | $2.55 -4.14% -4.31% 240K |

| -3.62% | O: 1.09% H: 1.79% C: -4.66%
nxc-201 presentation cell biopharma for meeting therapy

---

Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
CRBU | $4.0 -1.72% -1.75% 1.3M |

Health Technology

| -3.1% | O: -0.71% H: 5.27% C: -2.4%
presentation cell meeting therapy

---

Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
LGVN P 3 d | $3.49 19.11% 16.05% 9.4M |

| 73.37% | O: 41.42% H: 42.68% C: 22.59%
conference disease association alzheimer’s presentation international research for trial

---

Hillman Sets First Quarter 2024 Earnings Release and Results Presentation Date
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
HLMN | $9.645 0.16% 0.16% 1.2M |

| -2.53% | O: 0.3% H: 0.05% C: -2.83%
first presentation results

---

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
TGTX | $14.02 -0.36% -0.36% 1.6M |

Health Technology

| -4.48% | O: -3.94% H: 3.0% C: -0.57%
briumvi neurology presentation sclerosis for meeting therapeutics

---

TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
TFFP | $3.52 -9.69% 27K |

Health Technology

| -11.34% | O: 0.25% H: 1.26% C: -11.56%
tacrolimus presentation positive sessions pharmaceuticals trial

---

Provectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC at AACR 2024 Annual Meeting
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
PVCT | $0.1675 -15.0% 52K |

Manufacturing

| -1.3% | O: 0.0% H: 17.21% C: 7.19%
pv-10 presentation cancer immunotherapy for meeting

---

Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
TLSA | $0.58 16.02% 13.81% 150K |

Health Technology

| 14.92% | O: 1.15% H: 9.66% C: 3.34%
life presentation foralumab sciences meeting imaging platform

---

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
STTK | $9.01 -0.88% -0.89% 240K |

Health Technology

| 1.0% | O: -1.11% H: 9.78% C: 9.66%
association presentation cancer research preclinical for meeting

---

Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform
Published: 2024-04-08 (Crawled : 21:00) - globenewswire.com
THTX | $1.29 -12.78% 12K |

Health Technology

| -4.96% | O: 4.96% H: 4.05% C: 4.05%
presentation preclinical platform

---

Theriva™ Biologics Announces Presentation at the American Society for Cell and Gene Therapy 27th Annual Meeting
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
TOVX | $0.4308 -4.16% 0.0% 14K |

Manufacturing

| -3.35% | O: 0.62% H: 2.02% C: -1.11%
presentation cell for meeting therapy

---

Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
Published: 2024-04-07 (Crawled : 00:00) - globenewswire.com
BDTX A | $5.34 2.3% 2.25% 310K |

Health Technology

| 4.82% | O: 5.22% H: 3.44% C: 2.1%
bdtx-1535 association presentation cancer research for meeting therapeutics

---

Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting
Published: 2024-04-07 (Crawled : 00:00) - globenewswire.com
REPL | $7.15 0.42% 0.42% 680K |

Health Technology

| -1.04% | O: 3.27% H: 0.13% C: -4.17%
association presentation cancer cell research meeting skin trial results

---

Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
Published: 2024-04-03 (Crawled : 11:00) - globenewswire.com
ATHA | $2.11 2.43% 2.37% 160K |

Health Technology

| -16.94% | O: -3.23% H: 0.0% C: 0.0%
pharma presentation meeting

---

MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)
Published: 2024-04-02 (Crawled : 23:00) - globenewswire.com
MNOV | $1.54 1.3% 24K |

Health Technology

| 3.36% | O: 2.01% H: 4.61% C: 0.0%
mn-166 presentation meeting trial results glioblastoma

---

Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
VRCA | $7.01 1.3% 1.28% 90K |

Health Technology

| 23.13% | O: -0.36% H: 6.25% C: 5.18%
conference presentation pharmaceuticals

---

Virco Issues Updated Investor Presentation
Published: 2024-04-01 (Crawled : 12:30) - globenewswire.com
VIRC | $10.495 3.4% 3.29% 180K |

Producer Manufacturing

| -7.14% | O: 1.37% H: 0.0% C: 0.0%
presentation

---

Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
CADL | $5.89 1.2% 1.19% 1.1M |

| Email alert Add to watchlist
can-3110 drug presentation update trial therapeutics glioblastoma

---

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
Published: 2024-03-26 (Crawled : 13:00) - globenewswire.com
HSCS | $0.1027 0.19% 0.19% 1.7M |

n/a

| -14.58% | O: 2.5% H: 0.0% C: -2.52%
myovista congress world presentation

---

TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting
Published: 2024-03-25 (Crawled : 13:00) - globenewswire.com
TFFP | $3.52 -9.69% 27K |

Health Technology

| -54.23% | O: 0.13% H: 3.77% C: -3.9%
lung tacrolimus presentation international pharmaceuticals meeting heart study

---

Gainers vs Losers

58%

42%

Top 10 Gainers

WISA 4 | $6.06 246.29% 71.12% 200M |

Electronic Technology

VIAO | $0.265 -13.96% 35.85% 960K |

Electronic Technology

JAGX | $0.178 49.83% 33.26% 600M |

Health Technology

SXTC | $1.68 43.59% 30.36% 34M |

Health Technology

DYNT | $0.531 43.36% 30.24% 22M |

Health Technology

KA | $0.4796 41.06% 29.11% 5.3M |

Manufacturing

PALI | $5.86 40.87% 29.01% 29M |

Manufacturing

CLNN | $0.319 -3.74% 28.75% 6.3M |

BSGM | $1.52 38.18% 27.63% 3.3M |

Health Technology

MCBC | $13.67 37.66% 27.36% 2.2M |

Finance

---

Your saved searches

---